Clinical trial
Phase 1 Suicide Plus Immune Gene Therapy for Advanced Melanoma
NCT03338777 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Suicide Plus Immune Gene Therapy for Advanced Melanoma
- Lead sponsor
- Hospital Italiano de Buenos Aires
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- February 20, 2020
- Completion date
- February 20, 2020
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.